Seno-suppressive molecules as new therapeutic perspectives in rheumatic diseases

[en] Over the past years, through in vitro studies and unique animal models, biologists and clinicians have demonstrated that cellular senescence is at the root of numerous age-related chronic diseases including osteoarthritis and osteoporosis. This non-proliferative cellular syndrome can modify other surrounding tissue-resident cells through the establishment of a deleterious catabolic and inflammatory microenvironment. Targeting these deleterious cells through local or systemic seno-therapeutic agent delivery in pre-clinical models improves dramatically clinical signs and extends health span. In this review, we will summarize the current knowledge on cellular senescence, list the different strategies for identifying seno-suppressive therapeutic agents and their translations to rheumatic diseases. © 2019 Elsevier Inc.

Disciplines :

Rheumatology

Author, co-author :

Tachikart, Y. ^✱; IRMB (Institut of Regenerative Medicine and Biotherapies), Inserm U1183, Univ Montpellier, Montpellier, France

MALAISE, Olivier ^✱; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de rhumatologie

Mumme, M.; IRMB (Institut of Regenerative Medicine and Biotherapies), Inserm U1183, Univ Montpellier, Montpellier, France, Clinic for Orthopedics and Traumatology, University Hospital of Basel, Basel, Switzerland

Jorgensen, C.; IRMB (Institut of Regenerative Medicine and Biotherapies), Inserm U1183, Univ Montpellier, Montpellier, France, Service de Rhumatologie, CHU La Peyronie, Montpellier, France

Brondello, J.-M.; IRMB (Institut of Regenerative Medicine and Biotherapies), Inserm U1183, Univ Montpellier, Montpellier, France

^✱ These authors have contributed equally to this work.

Language :

English

Title :

Seno-suppressive molecules as new therapeutic perspectives in rheumatic diseases

Publication date :

2019

Journal title :

Biochemical Pharmacology

ISSN :

0006-2952

eISSN :

1873-2968

Publisher :

Elsevier Inc.

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 19 January 2022

Statistics

Number of views

84 (2 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

He, S., Sharpless, N.E., Senescence in health and disease. Cell 169:6 (2017), 1000–1011.
Childs, B.G., Gluscevic, M., Baker, D.J., Laberge, R.M., Marquess, D., Dananberg, J., van Deursen, J.M., Senescent cells: an emerging target for diseases of ageing. Nat. Rev. Drug Discov. 16:10 (2017), 718–735.
Vicente, R., Mausset-Bonnefont, A.L., Jorgensen, C., Louis-Plence, P., Brondello, J.M., Cellular senescence impact on immune cell fate and function. Aging Cell 15:3 (2016), 400–406.
Coppé, J., Desprez, P., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5 (2010), 99–118.
Muñoz-Espín, D., Serrano, M., Cellular senescence: from physiology to pathology. Nat. Rev. Mol. Cell Biol. 15:7 (2014), 482–496.
Hernandez-Segura, A., Nehme, J., Demaria, M., Hallmarks of cellular senescence. Trends Cell Biol., 2018.
Hernandez-Segura, A., de Jong, T.V., Melov, S., Guryev, V., Campisi, J., Demaria, M., Unmasking transcriptional heterogeneity in senescent cells. Curr. Biol. 27:17 (2017), 2652–2660.e4.
Yun, M.H., Davaapil, H., Brockes, J.P., Recurrent turnover of senescent cells during regeneration of a complex structure. Elife, 4, 2015.
Demaria, M., Ohtani, N., Youssef, S.A., Rodier, F., Toussaint, W., Mitchell, J.R., Laberge, R.M., Vijg, J., Van Steeg, H., Dollé, M.E., Hoeijmakers, J.H., de Bruin, A., Hara, E., Campisi, J., An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31:6 (2014), 722–733.
Jeon, O.H., Kim, C., Laberge, R.M., Demaria, M., Rathod, S., Vasserot, A.P., Chung, J.W., Kim, D.H., Poon, Y., David, N., Baker, D.J., van Deursen, J.M., Campisi, J., Elisseeff, J.H., Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat. Med. 23:6 (2017), 775–781.
Farr, J.N., Xu, M., Weivoda, M.M., Monroe, D.G., Fraser, D.G., Onken, J.L., Negley, B.A., Sfeir, J.G., Ogrodnik, M.B., Hachfeld, C.M., LeBrasseur, N.K., Drake, M.T., Pignolo, R.J., Pirtskhalava, T., Tchkonia, T., Oursler, M.J., Kirkland, J.L., Khosla, S., Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med. 23:9 (2017), 1072–1079.
Sousa-Victor, P., Gutarra, S., García-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardí, M., Ballestar, E., González, S., Serrano, A.L., Perdiguero, E., Muñoz-Cánoves, P., Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 506:7488 (2014), 316–321.
Baker, D.J., Wijshake, T., Tchkonia, T., LeBrasseur, N.K., Childs, B.G., van de Sluis, B., Kirkland, J.L., van Deursen, J.M., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479:7372 (2011), 232–236.
Baker, D.J., Childs, B.G., Durik, M., Wijers, M.E., Sieben, C.J., Zhong, J., Saltness, R.A., Jeganathan, K.B., Verzosa, G.C., Pezeshki, A., Khazaie, K., Miller, J.D., van Deursen, J.M., Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530:7589 (2016), 184–189.
Lawrence, R.C., Felson, D.T., Helmick, C.G., Arnold, L.M., Choi, H., Deyo, R.A., Gabriel, S., Hirsch, R., Hochberg, M.C., Hunder, G.G., Jordan, J.M., Katz, J.N., Kremers, H.M., Wolfe, F., Workgroup, N.A.D., Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58:1 (2008), 26–35.
Guillemin, F., Rat, A.C., Mazieres, B., Pouchot, J., Fautrel, B., Euller-Ziegler, L., Fardellone, P., Morvan, J., Roux, C.H., Verrouil, E., Saraux, A., Coste, J., Group, O., Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey. Osteoarthrit. Cartil. 19:11 (2011), 1314–1322.
Le Pen, C., Reygrobellet, C., Gérentes, I., Financial cost of osteoarthritis in France. The “COART” France study. Joint Bone Spine 72:6 (2005), 567–570.
Thomas, A.C., Hubbard-Turner, T., Wikstrom, E.A., Palmieri-Smith, R.M., Epidemiology of posttraumatic osteoarthritis. J. Athl. Train 52:6 (2017), 491–496.
McAlindon, T.E., Bannuru, R.R., Sullivan, M.C., Arden, N.K., Berenbaum, F., Bierma-Zeinstra, S.M., Hawker, G.A., Henrotin, Y., Hunter, D.J., Kawaguchi, H., Kwoh, K., Lohmander, S., Rannou, F., Roos, E.M., Underwood, M., OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthrit. Cartil. 22:3 (2014), 363–388.
Ogata, T., Ideno, Y., Akai, M., Seichi, A., Hagino, H., Iwaya, T., Doi, T., Yamada, K., Chen, A.Z., Li, Y., Hayashi, K., Effects of glucosamine in patients with osteoarthritis of the knee: a systematic review and meta-analysis. Clin. Rheumatol. 37:9 (2018), 2479–2487.
Loeser, R.F., Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthrit. Cartil. 17:8 (2009), 971–979.
Scanzello, C.R., Goldring, S.R., The role of synovitis in osteoarthritis pathogenesis. Bone 51:2 (2012), 249–257.
Yu, D., Xu, J., Liu, F., Wang, X., Mao, Y., Zhu, Z., Subchondral bone changes and the impacts on joint pain and articular cartilage degeneration in osteoarthritis. Clin. Exp. Rheumatol. 34:5 (2016), 929–934.
Goldring, M., Goldring, S., Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann. N. Y. Acad. Sci. 1192:1 (2010), 230–237.
Martin, J.A., Buckwalter, J.A., Telomere erosion and senescence in human articular cartilage chondrocytes. J. Gerontol. A Biol. Sci. Med. Sci. 56:4 (2001), B172–B179.
Martin, J.A., Buckwalter, J.A., Human chondrocyte senescence and osteoarthritis. Biorheology 39:1–2 (2002), 145–152.
Philipot, D., Guérit, D., Platano, D., Chuchana, P., Olivotto, E., Espinoza, F., Dorandeu, A., Pers, Y.M., Piette, J., Borzi, R.M., Jorgensen, C., Noel, D., Brondello, J.M., p16INK4a and its regulator miR-24 link senescence and chondrocyte terminal differentiation-associated matrix remodelling in osteoarthritis. Arthrit. Res. Ther., 16(1), 2014, R58.
Cooper, C., Campion, G., Melton, L.J., Hip fractures in the elderly: a world-wide projection. Osteoporos. Int. 2:6 (1992), 285–289.
Wade, S.W., Strader, C., Fitzpatrick, L.A., Anthony, M.S., O'Malley, C.D., Estimating prevalence of osteoporosis: examples from industrialized countries. Arch. Osteoporos, 9, 2014, 182.
Bass, E., French, D.D., Bradham, D.D., Rubenstein, L.Z., Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann. Epidemiol. 17:7 (2007), 514–519.
Khosla, S., Burr, D., Cauley, J., Dempster, D.W., Ebeling, P.R., Felsenberg, D., Gagel, R.F., Gilsanz, V., Guise, T., Koka, S., McCauley, L.K., McGowan, J., McKee, M.D., Mohla, S., Pendrys, D.G., Raisz, L.G., Ruggiero, S.L., Shafer, D.M., Shum, L., Silverman, S.L., Van Poznak, C.H., Watts, N., Woo, S.B., Shane, E., A.S.f.B.a.M. Research. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 22:10 (2007), 1479–1491.
Shane, E., Burr, D., Abrahamsen, B., Adler, R.A., Brown, T.D., Cheung, A.M., Cosman, F., Curtis, J.R., Dell, R., Dempster, D.W., Ebeling, P.R., Einhorn, T.A., Genant, H.K., Geusens, P., Klaushofer, K., Lane, J.M., McKiernan, F., McKinney, R., Ng, A., Nieves, J., O'Keefe, R., Papapoulos, S., Howe, T.S., van der Meulen, M.C., Weinstein, R.S., Whyte, M.P., Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 29:1 (2014), 1–23.
Farr, J.N., Fraser, D.G., Wang, H., Jaehn, K., Ogrodnik, M.B., Weivoda, M.M., Drake, M.T., Tchkonia, T., LeBrasseur, N.K., Kirkland, J.L., Bonewald, L.F., Pignolo, R.J., Monroe, D.G., Khosla, S., Identification of senescent cells in the bone microenvironment. J. Bone Miner. Res. 31:11 (2016), 1920–1929.
Rudan, I., Sidhu, S., Papana, A., Meng, S.J., Xin-Wei, Y., Wang, W., Campbell-Page, R.M., Demaio, A.R., Nair, H., Sridhar, D., Theodoratou, E., Dowman, B., Adeloye, D., Majeed, A., Car, J., Campbell, H., Chan, K.Y., G.H.E.R.G. (GHERG), Prevalence of rheumatoid arthritis in low- and middle-income countries: a systematic review and analysis. J. Glob. Health, 5(1), 2015, 010409.
Schönland, S.O., Lopez, C., Widmann, T., Zimmer, J., Bryl, E., Goronzy, J.J., Weyand, C.M., Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc. Natl. Acad. Sci. U.S.A. 100:23 (2003), 13471–13476.
Colmegna, I., Diaz-Borjon, A., Fujii, H., Schaefer, L., Goronzy, J.J., Weyand, C.M., Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthrit. Rheum. 58:4 (2008), 990–1000.
Hohensinner, P.J., Goronzy, J.J., Weyand, C.M., Telomere dysfunction, autoimmunity and aging. Aging Dis. 2:6 (2011), 524–537.
Li, Y., Goronzy, J.J., Weyand, C.M., DNA damage, metabolism and aging in pro-inflammatory T cells: Rheumatoid arthritis as a model system. Exp. Gerontol. 105 (2018), 118–127.
Goronzy, J.J., Henel, G., Sawai, H., Singh, K., Lee, E.B., Pryshchep, S., Weyand, C.M., Costimulatory pathways in rheumatoid synovitis and T-cell senescence. Ann. N. Y. Acad. Sci. 1062 (2005), 182–194.
Nonomura, Y., Nagasaka, K., Hagiyama, H., Sekine, C., Nanki, T., Tamamori-Adachi, M., Miyasaka, N., Kohsaka, H., Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6. Arthrit. Rheum. 54:7 (2006), 2074–2083.
Sekine, C., Sugihara, T., Miyake, S., Hirai, H., Yoshida, M., Miyasaka, N., Kohsaka, H., Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors. J. Immunol. 180:3 (2008), 1954–1961.
Nasu, K., Kohsaka, H., Nonomura, Y., Terada, Y., Ito, H., Hirokawa, K., Miyasaka, N., Adenoviral transfer of cyclin-dependent kinase inhibitor genes suppresses collagen-induced arthritis in mice. J. Immunol. 165:12 (2000), 7246–7252.
Fessler, J., Raicht, A., Husic, R., Ficjan, A., Duftner, C., Schwinger, W., Dejaco, C., Schirmer, M., Premature senescence of T-cell subsets in axial spondyloarthritis. Ann. Rheum. Dis. 75:4 (2016), 748–754.
Dvergsten, J.A., Mueller, R.G., Griffin, P., Abedin, S., Pishko, A., Michel, J.J., Rosenkranz, M.E., Reed, A.M., Kietz, D.A., Vallejo, A.N., Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis. Arthritis Rheum. 65:8 (2013), 2201–2210.
't Hart, B.A., Chalan, P., Koopman, G., Boots, A.M., Chronic autoimmune-mediated inflammation: a senescent immune response to injury. Drug Discov. Today 18:7–8 (2013), 372–379.
Wiley, C.D., Velarde, M.C., Lecot, P., Liu, S., Sarnoski, E.A., Freund, A., Shirakawa, K., Lim, H.W., Davis, S.S., Ramanathan, A., Gerencser, A.A., Verdin, E., Campisi, J., Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 23:2 (2016), 303–314.
Chinta, S.J., Woods, G., Demaria, M., Rane, A., Zou, Y., McQuade, A., Rajagopalan, S., Limbad, C., Madden, D.T., Campisi, J., Andersen, J.K., Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson's disease. Cell Rep. 22:4 (2018), 930–940.
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A.C., Ding, H., Giorgadze, N., Palmer, A.K., Ikeno, Y., Hubbard, G.B., Lenburg, M., O'Hara, S.P., LaRusso, N.F., Miller, J.D., Roos, C.M., Verzosa, G.C., LeBrasseur, N.K., Wren, J.D., Farr, J.N., Khosla, S., Stout, M.B., McGowan, S.J., Fuhrmann-Stroissnigg, H., Gurkar, A.U., Zhao, J., Colangelo, D., Dorronsoro, A., Ling, Y.Y., Barghouthy, A.S., Navarro, D.C., Sano, T., Robbins, P.D., Niedernhofer, L.J., Kirkland, J.L., The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14:4 (2015), 644–658.
Fuhrmann-Stroissnigg, H., Niedernhofer, L.J., Robbins, P.D., Hsp90 inhibitors as senolytic drugs to extend healthy aging. Cell Cycle 17:9 (2018), 1048–1055.
Kochetkova, E.Y., Blinova, G.I., Bystrova, O.A., Martynova, M.G., Pospelov, V.A., Pospelova, T.V., Targeted elimination of senescent Ras-transformed cells by suppression of MEK/ERK pathway. Aging (Albany NY) 9:11 (2017), 2352–2375.
Zhang, X., Zhang, S., Liu, X., Wang, Y., Chang, J., Mackintosh, S.G., Tackett, A.J., He, Y., Lv, D., Laberge, R.M., Campisi, J., Wang, J., Zheng, G., Zhou, D., Oxidation resistance 1 is a novel senolytic target. Aging Cell, 2018, e12780.
Baar, M.P., Brandt, R.M.C., Putavet, D.A., Klein, J.D.D., Derks, K.W.J., Bourgeois, B.R.M., Stryeck, S., Rijksen, Y., van, H., Willigenburg, Feijtel, D.A., van der, I., Pluijm, Essers, J., van Cappellen, W.A., van IJcken, W.F., Houtsmuller, A.B., Pothof, J., de Bruin, R.W.F., Madl, T., Hoeijmakers, J.H.J., Campisi, J., de Keizer, P.L.J., Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 169 (2017), 132–147.e16.
Fuhrmann-Stroissnigg, H., Ling, Y.Y., Zhao, J., McGowan, S.J., Zhu, Y., Brooks, R.W., Grassi, D., Gregg, S.Q., Stripay, J.L., Dorronsoro, A., Corbo, L., Tang, P., Bukata, C., Ring, N., Giacca, M., Li, X., Tchkonia, T., Kirkland, J.L., Niedernhofer, L.J., Robbins, P.D., Identification of HSP90 inhibitors as a novel class of senolytics. Nat. Commun., 8(1), 2017, 422.
Zhu, Y., Tchkonia, T., Fuhrmann-Stroissnigg, H., Dai, H.M., Ling, Y.Y., Stout, M.B., Pirtskhalava, T., Giorgadze, N., Johnson, K.O., Giles, C.B., Wren, J.D., Niedernhofer, L.J., Robbins, P.D., Kirkland, J.L., Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell 15:3 (2016), 428–435.
Pan, J., Li, D., Xu, Y., Zhang, J., Wang, Y., Chen, M., Lin, S., Huang, L., Chung, E.J., Citrin, D.E., Hauer-Jensen, M., Zhou, D., Meng, A., Inhibition of Bcl-2/xl With ABT-263 selectively kills senescent type II pneumocytes and reverses persistent pulmonary fibrosis induced by ionizing radiation in mice. Int. J. Radiat. Oncol. Biol. Phys. 99:2 (2017), 353–361.
Talpaz, M., Shah, N.P., Kantarjian, H., Donato, N., Nicoll, J., Paquette, R., Cortes, J., O'Brien, S., Nicaise, C., Bleickardt, E., Blackwood-Chirchir, M.A., Iyer, V., Chen, T.T., Huang, F., Decillis, A.P., Sawyers, C.L., Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N. Engl. J. Med. 354:24 (2006), 2531–2541.
Xu, M., Pirtskhalava, T., Farr, J.N., Weigand, B.M., Palmer, A.K., Weivoda, M.M., Inman, C.L., Ogrodnik, M.B., Hachfeld, C.M., Fraser, D.G., Onken, J.L., Johnson, K.O., Verzosa, G.C., Langhi, L.G.P., Weigl, M., Giorgadze, N., LeBrasseur, N.K., Miller, J.D., Jurk, D., Singh, R.J., Allison, D.B., Ejima, K., Hubbard, G.B., Ikeno, Y., Cubro, H., Garovic, V.D., Hou, X., Weroha, S.J., Robbins, P.D., Niedernhofer, L.J., Khosla, S., Tchkonia, T., Kirkland, J.L., Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24:8 (2018), 1246–1256.
Freund, A., Laberge, R.M., Demaria, M., Campisi, J., Lamin B1 loss is a senescence-associated biomarker. Mol. Biol. Cell 23:11 (2012), 2066–2075.
Glück, S., Guey, B., Gulen, M.F., Wolter, K., Kang, T.W., Schmacke, N.A., Bridgeman, A., Rehwinkel, J., Zender, L., Ablasser, A., Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat. Cell Biol. 19:9 (2017), 1061–1070.
Haag, S.M., Gulen, M.F., Reymond, L., Gibelin, A., Abrami, L., Decout, A., Heymann, M., van der Goot, F.G., Turcatti, G., Behrendt, R., Ablasser, A., Targeting STING with covalent small-molecule inhibitors. Nature 559:7713 (2018), 269–273.
Young, A.R., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J.F., Tavaré, S., Arakawa, S., Shimizu, S., Watt, F.M., Autophagy mediates the mitotic senescence transition. Genes Dev. 23:7 (2009), 798–803.
Tai, H., Wang, Z., Gong, H., Han, X., Zhou, J., Wang, X., Wei, X., Ding, Y., Huang, N., Qin, J., Zhang, J., Wang, S., Gao, F., Chrzanowska-Lightowlers, Z.M., Xiang, R., Xiao, H., Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence. Autophagy 13:1 (2017), 99–113.
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A.L., Sandri, M., Muñoz-Cánoves, P., Autophagy maintains stemness by preventing senescence. Nature 529:7584 (2016), 37–42.
Kwon, Y., Kim, J.W., Jeoung, J.A., Kim, M.S., Kang, C., Autophagy is pro-senescence when seen in close-up, but anti-senescence in long-shot. Mol. Cells 40:9 (2017), 607–612.
Mizushima, N., Levine, B., Autophagy in mammalian development and differentiation. Nat. Cell Biol. 12:9 (2010), 823–830.
Lee, I.H., Cao, L., Mostoslavsky, R., Lombard, D.B., Liu, J., Bruns, N.E., Tsokos, M., Alt, F.W., Finkel, T., A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. U.S.A. 105:9 (2008), 3374–3379.
Cuyàs, E., Verdura, S., Llorach-Parés, L., Fernández-Arroyo, S., Joven, J., Martin-Castillo, B., Bosch-Barrera, J., Brunet, J., Nonell-Canals, A., Sanchez-Martinez, M., Menendez, J.A., metformin is a direct SIRT1-activating compound: computational modeling and experimental validation. Front. Endocrinol. (Lausanne), 9, 2018, 657.
Moiseeva, O., Deschênes-Simard, X., St-Germain, E., Igelmann, S., Huot, G., Cadar, A.E., Bourdeau, V., Pollak, M.N., Ferbeyre, G., Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation. Aging Cell 12:3 (2013), 489–498.
Moiseeva, O., Deschênes-Simard, X., Pollak, M., Ferbeyre, G., Metformin, aging and cancer. Aging (Albany NY) 5:5 (2013), 330–331.
Moiseeva, O., Bourdeau, V., Roux, A., Deschênes-Simard, X., Ferbeyre, G., Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol. Cell. Biol. 29:16 (2009), 4495–4507.
Dörr, J.R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J.H., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., Kratzat, S., Purfürst, B., Walenta, S., Mueller-Klieser, W., Gräler, M., Hummel, M., Keller, U., Buck, A.K., Dörken, B., Willmitzer, L., Reimann, M., Kempa, S., Lee, S., Schmitt, C.A., Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 501:7467 (2013), 421–425.
Capell, B.C., Drake, A.M., Zhu, J., Shah, P.P., Dou, Z., Dorsey, J., Simola, D.F., Donahue, G., Sammons, M., Rai, T.S., Natale, C., Ridky, T.W., Adams, P.D., Berger, S.L., MLL1 is essential for the senescence-associated secretory phenotype. Genes Dev. 30:3 (2016), 321–336.
Segalés, J., Perdiguero, E., Muñoz-Cánoves, P., Regulation of muscle stem cell functions: a focus on the p38 MAPK signaling pathway. Front. Cell Dev. Biol., 4, 2016, 91.
Takayama, K., Kawakami, Y., Kobayashi, M., Greco, N., Cummins, J.H., Matsushita, T., Kuroda, R., Kurosaka, M., Fu, F.H., Huard, J., Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis. Arthritis Res. Ther., 16(6), 2014, 482.
Caramés, B., Hasegawa, A., Taniguchi, N., Miyaki, S., Blanco, F.J., Lotz, M., Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann. Rheum. Dis. 71:4 (2012), 575–581.
Ma, Y., Qi, M., An, Y., Zhang, L., Yang, R., Doro, D.H., Liu, W., Jin, Y., Autophagy controls mesenchymal stem cell properties and senescence during bone aging. Aging Cell, 17(1), 2018.
Parish, S.T., Wu, J.E., Effros, R.B., Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3. J. Immunol. 182:7 (2009), 4237–4243.
Kuilman, T., Michaloglou, C., Vredeveld, L.C., Douma, S., van Doorn, R., Desmet, C.J., Aarden, L.A., Mooi, W.J., Peeper, D.S., Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:6 (2008), 1019–1031.
Fleischmann, R., Kremer, J., Cush, J., Schulze-Koops, H., Connell, C.A., Bradley, J.D., Gruben, D., Wallenstein, G.V., Zwillich, S.H., Kanik, K.S., Investigators, O.S., Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. N. Engl. J. Med. 367:6 (2012), 495–507.
Fleischmann, R., Schiff, M., van der Heijde, D., Ramos-Remus, C., Spindler, A., Stanislav, M., Zerbini, C.A., Gurbuz, S., Dickson, C., de Bono, S., Schlichting, D., Beattie, S., Kuo, W.L., Rooney, T., Macias, W., Takeuchi, T., Baricitinib, methotrexate, or combination in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment, arthritis. Rheumatology 69:3 (2017), 506–517.
Däbritz, J.H., Yu, Y., Milanovic, M., Schönlein, M., Rosenfeldt, M.T., Dörr, J.R., Kaufmann, A.M., Dörken, B., Schmitt, C.A., CD20-targeting immunotherapy promotes cellular senescence in B-cell lymphoma. Mol. Cancer Ther. 15:5 (2016), 1074–1081.
Foroncewicz, B., Mucha, K., Paczek, L., Chmura, A., Rowiński, W., Efficacy of rapamycin in patient with juvenile rheumatoid arthritis. Transpl. Int. 18:3 (2005), 366–368.